- Home
- BORR vs OCS Comparison
BORR vs OCS Comparison
Compare BORR & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BORR
- OCS
- Stock Information
- Founded
- BORR 2016
- OCS 2003
- Country
- BORR Bermuda
- OCS Switzerland
- Employees
- BORR N/A
- OCS N/A
- Industry
- BORR Oil & Gas Production
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- BORR Energy
- OCS Health Care
- Exchange
- BORR Nasdaq
- OCS Nasdaq
- Market Cap
- BORR 941.4M
- OCS 863.5M
- IPO Year
- BORR 2019
- OCS N/A
- Fundamental
- Price
- BORR $2.20
- OCS $18.84
- Analyst Decision
- BORR Buy
- OCS Strong Buy
- Analyst Count
- BORR 1
- OCS 4
- Target Price
- BORR $9.00
- OCS $28.75
- AVG Volume (30 Days)
- BORR 7.0M
- OCS 51.8K
- Earning Date
- BORR 02-19-2025
- OCS 03-11-2025
- Dividend Yield
- BORR 3.63%
- OCS N/A
- EPS Growth
- BORR 255.56
- OCS N/A
- EPS
- BORR 0.32
- OCS N/A
- Revenue
- BORR $1,010,600,000.00
- OCS $757,024.00
- Revenue This Year
- BORR $8.35
- OCS $8.06
- Revenue Next Year
- BORR $6.39
- OCS $638.57
- P/E Ratio
- BORR $7.31
- OCS N/A
- Revenue Growth
- BORR 30.97
- OCS N/A
- 52 Week Low
- BORR $2.17
- OCS $10.55
- 52 Week High
- BORR $7.26
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- BORR 26.01
- OCS 39.20
- Support Level
- BORR $2.17
- OCS $17.92
- Resistance Level
- BORR $2.44
- OCS $19.22
- Average True Range (ATR)
- BORR 0.17
- OCS 0.62
- MACD
- BORR -0.02
- OCS -0.20
- Stochastic Oscillator
- BORR 2.93
- OCS 33.25
About BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.